Pharma companies tend to use the “essential medicines” term in a much broader sense than the WHO definition

Pharma stocks are showing strength. Charts predict this name could break out next

Research Reveals Persistent Drug Pricing Distortions from PBM-Owned Pharmaceutical Companies

The article examines the persistent distortions in U.S. drug pricing, particularly focusing on vertically integrated pharmacy benefit manage

The public health impact of the Medicines Patent Pool increases with the fragmentation of intellectual property rights

Recent moves of note in and around the biotech and pharma industries

Five EU countries seek unified response to US and pharma pressure on drug pricing

Five EU countries are calling for a united European response to pressure from the U.S. and pharmaceutical companies demanding higher drug pr

Traitements contre le cancer : «La Chine est en train de devenir le leader mondial du médicament»